Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.
J Neurol
; 269(3): 1463-1469, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-34292396
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
/
Middle aged
Language:
En
Journal:
J Neurol
Year:
2022
Document type:
Article